Phospholipid derivatives and their use as medicaments
US11414443B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Mar 29, 2018 |
| Grant date | Aug 16, 2022 |
| Priority date | — |
| Expiry date | Mar 29, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/704
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to 1-acyl-lysophosphatidyl derivatives of general formula I; in which R is C4 to C30 aliphatic hydrocarbyl chain, R1 is selected from H or C1 to C10 alkyl, preferably C1 to C6 alkyl, R2 is selected from H, C10 to C30 acyl or C1 to C10 alkyl, preferably C1 to C6 alkyl, and R3, when present, is selected from H or C1 to C10 alkyl, preferably C1 to C6 alkyl. These derivatives are intended for the treatment of cancer, in particular melanoma, hepatocarcinoma or GIT carcinomas.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.